Search results for: 'deal chapter strategi 2025'
- Did you mean
- deal captur strategi 2025
- Related search terms
- deal+on+demand
- deal+texas+and+benchmarking
- deals+on+demand
- deal+terms+and+benchmarking
- deal+teva+and+benchmarking
-
Oncology Collaboration and Licensing Deals 2020-2025July 2025$4,995.00
Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2020 to 2025
Learn More -
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology 2016-2025April 2025$3,995.00
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2025
Learn More -
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025April 2025$3,995.00
Track JV activity across pharma and biotech with real-world examples, financial terms, and partnering trends—includes access to contract documents where available.
Learn More -
Dermatology Collaboration and Licensing Deals 2016-2025April 2025$3,995.00
Dermatology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Autoimmune Collaboration and Licensing Deals 2016-2025April 2025$3,995.00
Autoimmune Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Companion Diagnostic Collaboration and Licensing Deals 2010-2025May 2025$3,995.00
Companion Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2010 to 2025
Learn More -
Diagnostic Collaboration and Licensing Deals 2020-2025May 2025$3,995.00
Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2020 to 2025
Learn More -
In Vitro Diagnostic Collaboration and Licensing Deals 2016-2025May 2025$3,995.00
In Vitro Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2025May 2025$3,995.00
Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025March 2025$4,995.00
The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to preclinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More